Disorders of the nervous system include various categories of diseases affecting neural function.
Alzheimer's Disease
Most common cause of dementia; affects ~0.5-0.6% of the global population (approximately 50 million people).
Incidence increases with age: 7-10% for those over 65, 40% for those over 80.
Symptoms include cognitive impairment, memory loss, and disorientation.
Pathology includes neurofibrillary tangles and amyloid plaques leading to neuronal degeneration.
Parkinson's Disease
Second most common neurodegenerative disease, affecting 0.2% of the world's population.
Characterized by tremors, rigidity, and motion difficulties due to dopaminergic neuron degeneration.
Age is the biggest risk factor; most cases arise after 50.
Multiple Sclerosis (MS)
Affects ~2.5 million people globally, with lesions in CNS myelin leading to motor and sensory defects.
Can be classified into four types:
Relapsing-Remitting (RRMS) - alternating periods of recovery and relapse.
Secondary Progressive (SPMS) - gradual deterioration post-RRMS.
Primary Progressive (PPMS) - steadily progressive without remissions.
Progressive Relapsing (PRMS) - progressive deterioration during relapse phases.
Guillain-Barré Syndrome
Rare autoimmune condition triggered by infections, attacking Schwann cell myelin, leading to paralysis.
Charcot-Marie-Tooth Disease
Inherited peripheral neuropathy, impacting motor and sensory nerves, with a prevalence of 1 in 2500.
Death rates from Alzheimer’s disease more than doubled between 2000 and 2019, becoming a leading cause of death in high-income countries.
In the UK, Alzheimer’s and dementia are now the leading causes of death for females.
DALY Calculation = YLL (Years of Life Lost) + YLD (Years Lived with Disability)
1 DALY represents 1 year of full health lost.
Neurological conditions accounted for a significant DALYs burden, particularly Alzheimer's and other dementias.
Major risk factors include age, genetic mutations (e.g., in APP and presenilin genes), and environmental factors (e.g., aluminum exposure).
Late-onset and early-onset Alzheimer’s can be influenced by different genetic and environmental components.
Genetic factors play a significant role, including SNCA gene mutation related to alpha-synuclein.
Environmental factors may exacerbate the condition.
Alzheimer's Disease:
Acetylcholinesterase inhibitors (e.g., donepezil) to alleviate symptoms.
Memantine to regulate glutamate and protect neurons.
Parkinson’s Disease:
L-DOPA to increase dopamine levels.
Surgical options like Deep Brain Stimulation and emerging therapies such as cell replacement.
Diagnosis includes neurological exams and MRI; treated with β-interferons and monoclonal antibodies to reduce inflammation.
Understand prevalence and burden of these diseases.
Distinguish categories of diseases, symptoms, affected regions, and types of nervous systems involved (CNS or PNS).
Identify current and possible future treatments and their mechanisms.